Bambusa Therapeutics Files Prospectus To Sell Up To 9.375M IPO Shares

This is Bambusa Therapeutics, Inc.’s initial public offering. We are selling 9,375,000 shares of our common stock.
We expect the public offering price to be between $15.00 and $17.00 per share. Prior to this offering, there has been no public market for our common stock. We have applied to list our common stock on the Nasdaq Global Select Market ("Nasdaq") under the symbol "BBTX." The closing of this offering is contingent upon such listing.
We are an "emerging growth company" and a "smaller reporting company" as defined under the federal securities laws and, as such, have elected to comply with certain reduced public company reporting requirements in this prospectus and may elect to do so in future filings. See "Prospectus Summary—Implications of Being an Emerging Growth Company and a Smaller Reporting Company."
Investing in our common stock involves risks that are described in the section titled "Risk Factors" beginning on page 16 of this prospectus.
At our request, the underwriters have reserved up to 3.5% of the shares of common stock offered by this prospectus for sale, at the initial public offering price, to certain persons associated with us. See the section titled "Underwriting—Reserved Share Program."
The underwriters may also exercise their option to purchase up to 1,406,250 additional shares from us, at the public offering price, less the underwriting discount, for 30 days after the date of this prospectus.